Professur für Chirurgische Forschung

Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis (2022) Mahajan UM, Oehrle B, Sirtl S, Alnatsha A, Goni E, Regel I, Beyer G, et al. Journal article Microfluidic Technology for the Isolation and Analysis of Exosomes (2022) Wu Y, Wang Y, Lu Y, Luo X, Huang Y, Xie T, Pilarsky C, et al. Journal article, Review article GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma (2022) De Andres MP, Jackson RJ, Felipe I, Zagorac S, Pilarsky C, Schlitter AM, Martinez De Villareal J, et al. Journal article An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer (2022) Yun D, Yang Z, Zhang S, Yang H, Liu D, Grützmann R, Pilarsky C, Britzen-Laurent N Journal article A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing (2022) Chen XZ, Guo R, Zhao C, Xu J, Song H, Yu H, Pilarsky C, et al. Journal article, Review article Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer (2022) Yang H, Liu B, Liu D, Yang Z, Zhang S, Xu P, Xing Y, et al. Journal article Application of microfluidic chips in anticancer drug screening (2022) Fan XY, Deng ZF, Yan YY, E Orel V, Shypko A, B Orel V, Ivanova D, et al. Journal article, Review article Filamin A Is a Potential Driver of Breast Cancer Metastasis via Regulation of MMP-1 (2022) Zhou J, Wu L, Xu P, Li Y, Ji Z, Kang X Journal article CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer (2022) Lan B, Zeng S, Zhang S, Ren X, Xing Y, Kutschick I, Pfeffer S, et al. Journal article Microfluidics applications for high-throughput single cell sequencing (2021) Zhou WM, Yan YY, Guo QR, Ji H, Wang H, Xu TT, Makabel B, et al. Journal article, Review article